Stuart Rich
Chief Medical Officer, Director · TENAX THERAPEUTICS, INC.
- 2024
- Dec 5, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stuart Rich files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ADAR1 Capital Management, LLC - $4.80M in TENX purchases and sales in the last 12 months
- Declan Doogan - $102K in TENX purchases and sales in the last 12 months
- Thomas McGauley - $58K in TENX purchases and sales in the last 12 months
- Christopher Thomas Giordano - $40K in TENX purchases and sales in the last 12 months
- June Sherie Almenoff - $15K in TENX purchases and sales in the last 12 months
- Thomas R. Staab II - $11K in TENX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stuart Rich?
Stuart Rich is a corporate insider, tracked as Chief Medical Officer, Director of TENAX THERAPEUTICS, INC. (TENX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Stuart Rich last file a Form 4?
The most recent primary Form 4 on record is dated 5 December 2025, one of 2 filings going back to 2024.
Has Stuart Rich been buying or selling stock?
Recorded transactions: 3 open-market purchases ($46K) and 0 open-market sales across all tracked filings.
